Daylight Savings linked to increased medical errors

Article

Human errors including medications, administering either the wrong dose or the wrong drug, seem to increase by 18 percent

Although the U.S. is about to “fall back” with the end of 2020’s Daylight Savings Time (DST), research has showed that the start of DST may be behind medical errors.

Medical errors are more likely to occur in the days following the “spring ahead” DST switch, an observational study found.1

As part of the Mayo Clinic Health System, healthcare workers are encouraged to voluntarily report patient safety-related incidents caused by defective systems, equipment, or human error. The data collected from this record of reports was examined for errors in the 7 days preceding and following the spring and fall time changes, over a period of 8 years.

By and large, there were no substantial differences in errors reported in the weeks before and after DST. However, when researchers constrained their analysis to only human errors, they found a statistically significant increase of 18.7 percent human errors when an hour was lost in the spring. The majority of errors occurring during this time involved medications, administering either the wrong dose or the wrong drug.

When it came to the fall switch back to standard time, when an hour is gained, there were no significant differences in human errors in the weeks preceding and following DST.

Delayed start times and other contingency measures are suggested to help mitigate the increased risk of errors in the spring.

Do you plan to hand out candy to trick or treaters this Halloween, during the pandemic?

Reference

1. Kolla BP, Coombes BJ, Morgenthaler TI, Mansukhani MP. Increased Patient Safety-Related Incidents Following the Transition into Daylight Savings Time. J Gen Intern Med. 2020. DOI: s11606-020-06090-9.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.